Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2017 - 2025)

Historic Amortizatization of Intangibles for Collegium Pharmaceutical (COLL) over the last 9 years, with Q3 2025 value amounting to $55.5 million.

  • Collegium Pharmaceutical's Amortizatization of Intangibles rose 3595.99% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.9 million, marking a year-over-year increase of 5371.99%. This contributed to the annual value of $165.3 million for FY2024, which is 1340.83% up from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Amortizatization of Intangibles is $55.5 million, which was up 3595.99% from $55.5 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Amortizatization of Intangibles ranged from a high of $55.5 million in Q1 2025 and a low of $16.8 million during Q1 2021
  • In the last 5 years, Collegium Pharmaceutical's Amortizatization of Intangibles had a median value of $37.5 million in 2023 and averaged $35.8 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Amortizatization of Intangibles skyrocketed by 15173.56% in 2022, and later crashed by 1836.61% in 2023.
  • Collegium Pharmaceutical's Amortizatization of Intangibles (Quarter) stood at $16.8 million in 2021, then skyrocketed by 151.74% to $42.3 million in 2022, then dropped by 18.37% to $34.5 million in 2023, then soared by 60.72% to $55.5 million in 2024, then grew by 0.0% to $55.5 million in 2025.
  • Its last three reported values are $55.5 million in Q3 2025, $55.5 million for Q2 2025, and $55.5 million during Q1 2025.